HOUGEN ELIZABETH L - 28 Dec 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Signature
By: Patrick R. O'Neil, attorney-in-fact For: Elizabeth L. Hougen
Issuer symbol
IONS
Transactions as of
28 Dec 2023
Net transactions value
-$70,848
Form type
4
Filing time
02 Jan 2024, 17:54:31 UTC
Previous filing
02 Mar 2023
Next filing
04 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $2,140,952 +45,225 +60% $47.34 120,884 28 Dec 2023 Direct
transaction IONS Common Stock Tax liability $2,211,799 -43,798 -36% $50.50 77,086 28 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -45,225 -100% $0.000000* 0 28 Dec 2023 Common Stock 45,225 $47.34 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options. The reporting person received 1,427 shares of common stock on net exercise of option to purchase 45,225 shares of common stock. Pursuant to the terms of the Company's 2011 Equity Incentive Plan, the Company withheld 43,798 shares of common stock underlying the option for payment of the exercise price and tax withholdings using the closing stock price on December 28, 2023 of $50.50.